JUPITER ORPHAN THERAPEUTICS
Jupiter Orphan Therapeutics, Inc. (JOT) is a specialty pharmaceutical company developing therapies for rare diseases linked to single gene deficiencies. JOT, a Delaware Corporation with it's principal office located in Jupiter, FL, USA, was founded in the summer of 2015. In its short period of operations, JOT has assembled a very strong management and scientific team as well as defined three pipeline products which of one is already in Phase II.
JUPITER ORPHAN THERAPEUTICS
Industry:
Genetics Pharmaceutical
Founded:
2015-01-01
Address:
Jupiter, Florida, United States
Country:
United States
Website Url:
http://www.jupiterorphan.com
Total Employee:
1+
Status:
Active
Contact:
+115613087780
Email Addresses:
[email protected]
Total Funding:
2.75 M USD
Technology used in webpage:
Euro Amazon Google Apps For Business Amazon Oregon Region Register.com DNS
Similar Organizations
Aratana Therapeutics
Aratana Therapeutics develops innovative therapies for the animal health industry.
Bluebird Bio
Bluebird Bio offers products based on the transformative potential of gene therapy for patients with genetic and orphan diseases.
Emmaus Medical
Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.
Sirnaomics
Sirnaomics is a biopharmaceutical company developing therapeutics for critical human diseases by using RNA interference technology.
Syros Pharmaceuticals
Syros Pharmaceuticals is a life sciences company that focuses on treating diseases by mapping gene regulatory circuits.
Voyager Therapeutics
Voyager Therapeutics is a biotechnology company specializing in gene therapy and neurology.
Current Employees Featured
Founder
Investors List
Tarnagulla Ventures
Tarnagulla Ventures investment in Seed Round - Jupiter Orphan Therapeutics
Official Site Inspections
http://www.jupiterorphan.com
Unable to get host informations!!!
More informations about "Jupiter Orphan Therapeutics"
Jupiter Orphan Therapeutics - Crunchbase Company Profile
Jupiter Orphan Therapeutics, Inc. (JOT) is a specialty pharmaceutical company developing therapies for rare diseases linked to single gene deficiencies. JOT, a Delaware Corporation …See details»
Home - Jupiter Neurosciences, Inc
The first of its kind . The anti-inflammatory, oxidative-stress-reducing, and other mechanisms of action enable Jupiter Neurosciences flagship product, JOTROL™, to have multiple potential …See details»
Company - Jupiter Neurosciences, Inc
Alexander Rosén is a Co-Founder and Chief Administrative Officer at Jupiter Orphan Therapeutics, Inc and has been with the Company since its inception. ... designing and …See details»
Corporate Fact Sheet - jupiterneurosciences.com
Organization dedicated to the pursuit of scientific research leading to treatments and a cure for Friedreich's ataxia. • numerousCatalent, Inc.: world's #1 drug development, delivery, and …See details»
Jupiter Orphan Therapeutics, Inc. Announces New Corporate …
JUPITER, Fla., Sept. 14, 2021 /PRNewswire/ -- Jupiter Orphan Therapeutics, Inc., a clinical stage pharmaceutical company focused on treating central nervous system (CNS) disorders and rare ...See details»
Jupiter Orphan Therapeutics, Inc. Enters into a Global ... - PRWeb
Jan 12, 2016 Jupiter Orphan Pharmaceuticals, Inc. was recently formed to address rare diseases caused by, or related to, single gene deficiencies. JOT co-founders Christer Rosén …See details»
Jupiter Orphan Therapeutics Receives Orphan Drug Designation …
JUPITER, Fla., Aug. 22, 2017 /PRNewswire/ -- Jupiter Orphan Therapeutics, Inc. ("JOT"), Jupiter, FL, today announced that it has received notification from the US Food and Drug …See details»
Jupiter Orphan Therapeutics - Crunchbase
Jupiter Orphan Therapeutics, Inc. Developing therapies for rare diseases linked to single gene deficiencies.See details»
Jupiter Orphan Therapeutics - Directors Team - The Org
The Directors Team at Jupiter Orphan Therapeutics, Inc. provides strategic leadership and oversight for the development of innovative therapies targeting rare diseases caused by single …See details»
Allison W. Brady - Director at Jupiter Orphan Therapeutics - The Org
Director at Jupiter Orphan Therapeutics. Contact. For over 25 years, Allison W. Brady has been a passionate fundraiser and advocate for rare diseases medical research and patients. She …See details»
Investing in Alzheimer’s Treatment: Join Jupiter Orphan …
Mar 23, 2021 Christer Rosén, Chairman-CEO & Founder of Jupiter Orphan Therapeutics, Inc, Raymond “Scott” Turner MD, Professor Neurology, Georgetown University (Alzheimer’s …See details»
Jupiter Orphan Therapeutics, Inc. Strengthens its Advisory Positions
May 5, 2020 /PRNewswire/ -- Jupiter Orphan Therapeutics, Inc. (JOT) today announced that it is strengthening its Scientific Advisory Board with the addition of Dr. Charbel...See details»
W. Dalton Dietrich III - Scientific Advisor at Jupiter Orphan ...
Scientific Advisor at Jupiter Orphan Therapeutics. Join to edit. About. Dr. Dalton Dietrich is Scientific Director at The Miami Project to Cure Paralysis and the Kinetic Concepts …See details»
Jupiter Orphan Therapeutics in Process to Submit IND for
Feb 5, 2018 This will be the first of several anticipated IND submissions in 2018 utilizing JOT's platform product, JOTROL.See details»
Jupiter Neurosciences, Inc. has completed an IPO in the amount of …
Dec 2, 2024 Jupiter Neurosciences, Inc. is a clinical-stage research and development pharmaceutical company. The Company has developed a resveratrol platform product …See details»
11 Best Startups in Jupiter Florida to Watch in 2025
Jupiter Orphan Therapeutics, Inc. 5. Funding Rounds. $6.4m. Money raised. Jupiter Orphan Therapeutics is devoted to the development of clinical stage drugs for the treatment of rare …See details»
Jupiter orphan therapeutics, inc. - Email Address & Phone Number …
Reach decision-makers at Jupiter Orphan Therapeutics, Inc.. Find their phone numbers & email addresses. It’s free. - LushaSee details»
Jupiter Orphan Therapeutics Announces Favorable Data Which …
JUPITER, Fla., Aug. 22, 2018 /PRNewswire/ -- Jupiter Orphan Therapeutics, Inc. ("JOT"), Jupiter, FL, today announced that it has received new data regarding an increase in mitochondrial …See details»
Jupiter Orphan Therapeutics Announces First Patient Dosed in …
Jan 11, 2021 For more information about Jupiter Orphan Therapeutics and JOTROLTM, visit www.jupiterorphan.com. Company contact: Christer Rosén, Chairman and CEO [email …See details»
Scorpio Daily Horoscope By Astrologer Susan Taylor
2 days ago Scorpio daily horoscope - Dive deep into your destiny! Susan Taylor unravels the secrets of today’s planetary energies—don’t miss out! Read now!See details»